Chugai Pharmaceutical , Ltd. Inventory

The latest inventory for CHGCF is $320B as of June 2026. That compares with $240B in the prior-year period — up 33.9% year over year. Investors often review this figure alongside Chugai Pharmaceutical , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, CHGCF's inventory moved from $240B to $320B — a 33.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Chugai Pharmaceutical , Ltd.'s operating scale or balance-sheet position.

A inventory figure of $320B for CHGCF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CHGCF's inventory ($320B), review year-over-year change from $240B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.